Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, United States.
Drug Alcohol Depend. 2012 Jul 1;124(1-2):167-71. doi: 10.1016/j.drugalcdep.2011.12.009. Epub 2012 Jan 21.
There is evidence for psychomotor and cognitive performance impairment in methadone maintenance patients (MMP), as well as in individuals with current cocaine dependence. It is unknown whether MMP with concurrent cocaine dependence perform worse on tests of cognitive function than MMP without cocaine dependence.
Performance was compared between MMP with and without current cocaine dependence (MMP/CD+; N = 53 and MMP/CD-; N = 24) on a standard battery of tasks designed to measure psychomotor performance, attention, episodic and working memory, and executive function.
Participant characteristics were mostly similar across groups. However, the MMP/CD+ group had a shorter duration of methadone treatment, and a larger percentage of participants with self-reported 30-day poly-substance abuse and positive urine drug tests on the day of cognitive testing. There were no differences between the groups on measures of balance, psychomotor coordination, divided attention, working memory, most measures of episodic memory, or executive function. Relative to MMP/CD-, MMP/CD+ showed significant impairment on select measures of psychomotor performance/attention (simple reaction time and trail-making test A) and episodic memory (higher false alarm rates on recognition memory).
The absence of differences between MMP/CD+ and MMP/CD- on measures of higher order cognitive functions, and the relatively small magnitude between-group differences on other measures suggest that current cocaine dependence, in the absence of cocaine intoxication, is unlikely to be associated with clinically meaningful increases in performance impairment in MMP.
美沙酮维持治疗患者(MMP)以及当前可卡因依赖个体存在精神运动和认知表现受损的证据。目前尚不清楚是否同时患有可卡因依赖的 MMP 在认知功能测试中的表现是否比没有可卡因依赖的 MMP 更差。
在一套旨在测量精神运动表现、注意力、情节和工作记忆以及执行功能的标准测试中,比较了当前可卡因依赖的 MMP(MMP/CD+;N=53)和没有可卡因依赖的 MMP(MMP/CD-;N=24)之间的表现。
参与者的特征在两组之间大多相似。然而,MMP/CD+组的美沙酮治疗持续时间较短,且在认知测试当天,有更多的参与者报告了 30 天的多物质滥用和尿液药物检测呈阳性。在平衡、精神运动协调、分散注意力、工作记忆、大多数情节记忆测量或执行功能方面,两组之间没有差异。与 MMP/CD-相比,MMP/CD+在精神运动表现/注意力(简单反应时间和 Trail-Making 测试 A)和情节记忆(识别记忆中的错误警报率较高)的特定测量上表现出显著受损。
在高阶认知功能测量上,MMP/CD+和 MMP/CD-之间没有差异,在其他测量上,组间差异相对较小,这表明在没有可卡因中毒的情况下,当前可卡因依赖不太可能与 MMP 中的认知表现受损程度显著增加相关。